Related Experiment Video
Updated: Aug 29, 2025
09:33
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
MYCN and Metabolic Reprogramming in Neuroblastoma
Mohit Bansal1, Anamika Gupta1, Han-Fei Ding1
1Division of Molecular and Cellular Pathology, Department of Pathology, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Cancers
|September 9, 2022
Summary
MYCN amplification drives high-risk neuroblastoma by altering cell metabolism. Understanding these metabolic changes, particularly transcriptional regulation, is key to developing new therapies for this deadly pediatric cancer.
Area of Science:
- Pediatric Oncology
- Cancer Metabolism
- Molecular Biology
Background:
- Neuroblastoma accounts for 15% of childhood cancer deaths.
- Genomic MYCN amplification drives high-risk neuroblastoma with poor survival rates (<50%).
- MYCN activation promotes tumor growth through metabolic reprogramming.
Purpose of the Study:
- To review the current understanding of metabolic reprogramming in neuroblastoma.
- To focus on transcriptional regulation as a driver of metabolic changes.
- To identify areas for developing metabolism-based therapies.
Main Methods:
- Review of existing literature on neuroblastoma metabolism and MYCN.
- Analysis of transcriptional regulation's role in metabolic reprogramming.
- Identification of therapeutic vulnerabilities.
Main Results:
- MYCN-driven metabolic reprogramming fuels cancer cell growth and proliferation.
- Increased nutrient uptake, macromolecule synthesis, and energy production are key features.
- Metabolic reprogramming creates vulnerabilities exploitable for therapy.
Conclusions:
- Transcriptional regulation is a central mechanism in MYCN-driven metabolic reprogramming.
- Targeting metabolic pathways offers a promising therapeutic strategy for high-risk neuroblastoma.
- Further research is needed to translate these findings into effective clinical treatments.
Related Concept Videos
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:29Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:06Induced Pluripotent Stem Cells
4.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.3K
01:24Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K